In some experiments, panned RGCs plated in columns 2 to 6 in 24-welled culture dishes were pharmacologically treated with glutamate, glutamate agonists, glutamate antagonists, ACh, ACh agonists, or ACh antagonists. In other experiments, a combination of these agents was applied. All agents were directly applied to individual culture wells to obtain a variety of agent concentrations. All agonists and antagonists were obtained from Sigma (St. Louis, MO): (agonists) glutamate, N-methyl-D-aspartate (NMDA), kainic acid (KA), ACh, choline, and nicotine; (antagonists) 6-cyano-7-nitroquino-xaline-2,3-dione (CNQX), 2-amino 7 phosphonoheptanoic acid (AP-7), 5 methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate (MK-801), α-bungarotoxin (α-Bgt), and methyllycaconitine, (MLA). Agonist and antagonist concentrations were determined from dose–response experiments. The minimal dosage that provided a maximum effect was used throughout the study.